In clinical practice, there have been reports of treatments for autoimmune diseases, human immunodeficiency virus infection, and chemotherapy for metastatic neoplasms with direct administration of IL-2 [52–54], although no disease has been attributed to IL-2 deficiency or excess [52]. This evidence concerns the gene IL2 and metastatic neoplasm.